286 Ch 285. Mitral, Tricuspid, Pulmonic Valve Disease and Transcatheter Therapies

MS 全球多為 rheumatic（亞洲、南美仍盛行）；echo Wilkins score 判斷可否 PMBV (percutaneous mitral balloon valvuloplasty)；MR 分 primary (degenerative, MV prolapse, IE, ruptured chord) vs secondary (functional from LV dilation/HF)；MitraClip / TEER 自 EVEREST II → COAPT / MITRA-FR 後成為 secondary MR 治療新里程碑；2024 TRANSFORM-HF / RESHAPE-HF2 補充功能性 MR 證據；TS / TR 多為 secondary functional from PH/RV dilation；TRICVALVE / TriClip / Pascal / Cardioband 為 2024 transcatheter TR 治療新利器；TRILUMINATE Pivotal 2023 顯示 TEER 改善 TR 嚴重度與 QOL；pulmonic valve 多為 congenital (TOF, PS)，TPVR (transcatheter pulmonary valve replacement) Melody/Harmony 廣泛應用。